Jyotishna Sunil Chari, a member of the promoter staff of Rossari Biotech, purchased 1.2 August 2025 from Sunil Srinivasan Chari to shop for 1.5 million fairness stocks of the corporate thru an off-market inter-se switch. This acquisition is two.71 % of the entire percentage capital.
This transaction is an inter-to switch of stocks between the promoters of the corporate (together with promoter staff) and falls underneath the exemption given underneath Law 10 (1) (A) (II) of SAST laws. The entire retaining of the promoter and promoter staff will stay identical earlier than and after the above inter-from transactions.
Acquisition main points
Shareholding main points
Previous to the purchase, Jyotishna Sunil Chari had 10,00,330 stocks, which was once 1.81 % of the entire percentage capital. After the purchase, shareholding has higher to twenty-five,00,330 stocks, which is 4.52 % of the entire percentage capital.
Previous to the purchase, Rossari Biotech had a complete percentage capital of ₹ 11.07 crore (₹ 2/- each and every 5,53,66,966 complete equipped fairness percentage). After the purchase, the entire percentage capital stays the similar on ₹ 11.07 crore (₹ 2/- each and every of five,53,66,966 best possible fairness stocks).
After the above acquisition, TC’s overall dilute stocks/balloting capital is calculated consistent with the diluted capital discussed within the shareholding trend filed for the quarter ended on 30 June 2025 with BSE Restricted and Nationwide Inventory Change of India Restricted.